Teva to sell generic OxyContin through end-2007

March 6 (Reuters) - Drugmaker Teva Pharmaceutical Industries Ltd. (TEVA.O: Quote, Profile, Research, Stock Buzz)(TEVA.TA: Quote, Profile, Research, Stock Buzz) said it will continue to sell the generic version of painkiller OxyContin tablets at least through the end of 2007.

In October 2006, Teva settled a patent dispute with privately held Purdue Frederick Co. and some affiliates over the generic version of Purdue's OxyContin.

(Reporting by John Tilak in Bangalore)

((Editing by Anil Kumar; Reuters Messaging: john.tilak.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: TEVA DRUG/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3117